Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 225

1.

[Serological and nutritional outcome of infants born to HIV positive mothers undergoing option B + therapy in Guédiawaye].

Baptiste DJ, Djibril D, Assane S, Ngagne M, Baly O, Ousmane N.

Pan Afr Med J. 2016 Dec 7;25:224. doi: 10.11604/pamj.2016.25.224.10441. eCollection 2016. French.

2.
3.

[Seroprevalence of HBsAg in pregnant women in central Morocco].

Sbiti M, Khalki H, Benbella I, Louzi L.

Pan Afr Med J. 2016 Jul 1;24:187. eCollection 2016. French.

4.

Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.

Cheeseman HM, Olejniczak NJ, Rogers PM, Evans AB, King DF, Ziprin P, Liao HX, Haynes BF, Shattock RJ.

J Virol. 2016 Dec 16;91(1). pii: e01762-16. Print 2017 Jan 1.

5.

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial).

Stek C, Schutz C, Blumenthal L, Thienemann F, Buyze J, Nöstlinger C, Ravinetto R, Wouters E, Colebunders R, Maartens G, Wilkinson RJ, Lynen L, Meintjes G.

JMIR Res Protoc. 2016 Aug 29;5(3):e173. doi: 10.2196/resprot.6046.

6.

Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.

Grooms TN, Vuong HR, Tyo KM, Malik DA, Sims LB, Whittington CP, Palmer KE, Matoba N, Steinbach-Rankins JM.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6518-6531. doi: 10.1128/AAC.00956-16. Print 2016 Nov.

7.

A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety.

Poizot-Martin I, Brégigeon S, Tamalet C, Bouabdallah R, Zaegel-Faucher O, Obry-Roguet V, Ivanova A, Cano CE, Solas C.

Case Rep Oncol Med. 2016;2016:8515218. doi: 10.1155/2016/8515218. Epub 2016 Jul 20.

8.

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy.

Lhomme E, Richert L, Moodie Z, Pasin C, Kalams SA, Morgan C, Self S, De Rosa SC, Thiébaut R.

PLoS One. 2016 Apr 28;11(4):e0152952. doi: 10.1371/journal.pone.0152952. eCollection 2016.

9.

Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.

Kessans SA, Linhart MD, Meador LR, Kilbourne J, Hogue BG, Fromme P, Matoba N, Mor TS.

PLoS One. 2016 Mar 17;11(3):e0151842. doi: 10.1371/journal.pone.0151842. eCollection 2016.

10.

High Rates of Exclusive Breastfeeding in Both Arms of a Peer Counseling Study Promoting EBF Among HIV-Infected Kenyan Women.

Bosire R, Betz B, Aluisio A, Hughes JP, Nduati R, Kiarie J, Chohan BH, Merkel M, Lohman-Payne B, John-Stewart G, Farquhar C.

Breastfeed Med. 2016 Mar;11(2):56-63. doi: 10.1089/bfm.2015.0071. Epub 2016 Feb 17.

11.

Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.

Baden LR, Karita E, Mutua G, Bekker LG, Gray G, Page-Shipp L, Walsh SR, Nyombayire J, Anzala O, Roux S, Laher F, Innes C, Seaman MS, Cohen YZ, Peter L, Frahm N, McElrath MJ, Hayes P, Swann E, Grunenberg N, Grazia-Pau M, Weijtens M, Sadoff J, Dally L, Lombardo A, Gilmour J, Cox J, Dolin R, Fast P, Barouch DH, Laufer DS; B003-IPCAVD004-HVTN091 Study Group..

Ann Intern Med. 2016 Mar 1;164(5):313-22. doi: 10.7326/M15-0880. Epub 2016 Feb 2.

12.

Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.

Patil S, Kumar R, Deshpande S, Samal S, Shrivastava T, Boliar S, Bansal M, Chaudhary NK, Srikrishnan AK, Murugavel KG, Solomon S, Simek M, Koff WC, Goyal R, Chakrabarti BK, Bhattacharya J.

J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.

13.

Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis.

Radzio J, Henning T, Jenkins L, Ellis S, Farshy C, Phillips C, Holder A, Kuklenyik S, Dinh C, Hanson D, McNicholl J, Heneine W, Papp J, Kersh EN, García-Lerma JG.

J Infect Dis. 2016 May 15;213(10):1541-5. doi: 10.1093/infdis/jiw002. Epub 2016 Jan 6.

14.

The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles.

Said JS, Trybala E, Görander S, Ekblad M, Liljeqvist JÅ, Jennische E, Lange S, Bergström T.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1049-57. doi: 10.1128/AAC.02132-15. Print 2016 Feb.

15.

Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.

Kasirye RP, Baisley K, Munderi P, Levin J, Anywaine Z, Nunn A, Kamali A, Grosskurth H.

AIDS. 2016 Feb 20;30(4):635-44. doi: 10.1097/QAD.0000000000000956.

16.

Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials.

Ayele HT, Mourik MS, Debray TP, Bonten MJ.

PLoS One. 2015 Nov 9;10(11):e0142290. doi: 10.1371/journal.pone.0142290. eCollection 2015. Review.

17.

Blocking CXCL9 Decreases HIV-1 Replication and Enhances the Activity of Prophylactic Antiretrovirals in Human Cervical Tissues.

Macura SL, Lathrop MJ, Gui J, Doncel GF, Asin SN, Rollenhagen C.

J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):474-82. doi: 10.1097/QAI.0000000000000891.

18.
19.

The role of Fc receptors in HIV prevention and therapy.

Boesch AW, Brown EP, Ackerman ME.

Immunol Rev. 2015 Nov;268(1):296-310. doi: 10.1111/imr.12339. Review.

20.

A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models.

Boyapalle S, Xu W, Raulji P, Mohapatra S, Mohapatra SS.

PLoS One. 2015 Sep 25;10(9):e0135288. doi: 10.1371/journal.pone.0135288. eCollection 2015.

Supplemental Content

Loading ...
Support Center